United Network for Organ Sharing Rule Changes and Their Effects on Kidney and Liver Transplant Outcomes

Exp Clin Transplant. 2022 Mar;20(3):246-252. doi: 10.6002/ect.2018.0311. Epub 2019 Mar 5.

Abstract

Objectives: Recent national organ distribution rule changes could have implications on distance between donor and recipient hospitals and cold ischemia time. With cold ischemia time being an unavoidable detriment to organ quality, any strategies that minimize it should maximize organ quality. This study evaluated the significance of the kidney allocation system and the Share 35 rule changes on kidney and liver transplant outcomes.

Materials and methods: This retrospective study included deceased liver and kidney donor and their recipient data from the Organ Procurement and Transplantation Network. Variables were analyzed using propensity score matching and Cox hazards model distance (from donor hospital to organ recovery center), and effects on survival outcomes of trans-planted livers and kidneys in the context of the recent rule changes were analyzed.

Results: Transplanted organs have significantly better outcomes when the distance is 0 miles versus median distances for locally transported organs of 18 and 22 miles for kidney and liver, respectively. Cold ischemia time, when corrected, accounts for this finding, thus suggesting that cold ischemia time is the factor most responsible for viability of a transplanted organ. This significance remains evident for liver transplants even after the Share 35 rule change but not for kidney transplants following the December 2014 kidney allocation system change.

Conclusions: Liver transplants showed a higher risk of lower viability with travel, and the Share 35 rule did not appear to change this result. Kidney transplant outcomes appear to have improved after the kidney allocation system change. Potential strategies for minimizing cold ischemia time and improving outcomes include more free-standing organ recovery centers in centralized locations.

MeSH terms

  • Graft Survival
  • Humans
  • Kidney
  • Liver Transplantation* / adverse effects
  • Retrospective Studies
  • Tissue Donors
  • Tissue and Organ Procurement*
  • Treatment Outcome
  • United States